Mental retardation interventions: Difference between revisions
Jump to navigation
Jump to search
| (4 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Treatment should address the underlying cause of ID, treatment of [[comorbid]] [[physical]] disorders that may further [[impair]] functioning, such as [[pharmacologic]] treatment for [[behavioral disorders]] in [[Fragile X]] patients, and institution of [[special education]], [[rehabilitation]], and [[psychosocial]] [[interventions]]. <ref name="HagermanPolussa2015">{{cite journal|last1=Hagerman|first1=Randi J.|last2=Polussa|first2=Jonathan|title=Treatment of the psychiatric problems associated with fragile X syndrome|journal=Current Opinion in Psychiatry|volume=28|issue=2|year=2015|pages=107–112|issn=0951-7367|doi=10.1097/YCO.0000000000000131}}</ref> <ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK332877/ |title=Clinical Characteristics of Intellectual Disabilities - Mental Disorders and Disabilities Among Low-Income Children - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | |||
==Indications== | ==Indications== | ||
The mainstay of treatment for | The mainstay of treatment for Mental retardation is medical therapy. | ||
==References== | ==References== | ||
Latest revision as of 02:38, 29 July 2021
|
Mental retardation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mental retardation interventions On the Web |
|
American Roentgen Ray Society Images of Mental retardation interventions |
|
Risk calculators and risk factors for Mental retardation interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Chelsea Mae Nobleza, M.D.[2]
Overview
Treatment should address the underlying cause of ID, treatment of comorbid physical disorders that may further impair functioning, such as pharmacologic treatment for behavioral disorders in Fragile X patients, and institution of special education, rehabilitation, and psychosocial interventions. [1] [2]
Indications
The mainstay of treatment for Mental retardation is medical therapy.
References
- ↑ Hagerman, Randi J.; Polussa, Jonathan (2015). "Treatment of the psychiatric problems associated with fragile X syndrome". Current Opinion in Psychiatry. 28 (2): 107–112. doi:10.1097/YCO.0000000000000131. ISSN 0951-7367.
- ↑ "Clinical Characteristics of Intellectual Disabilities - Mental Disorders and Disabilities Among Low-Income Children - NCBI Bookshelf".